CD4 and chronic kidney disease: As shown in Figure 4C, the expanded alloTregs from CKD patients and healthy individuals maintained their ability to inhibit the alloantigen-specific proliferation of CD4+ (left) and CD8+ (right) T cells under all inflammatory conditions used.